Cargando…
Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III
PURPOSE: Glycogen storage disease type III (GSDIII) is a uncommon autosomal recessive inherited metabolic disorder, which is caused by variants in the AGL gene. The purpose of this study was to elucidate the clinical and functional features of two novel variants in two families with GSDIIIa. METHODS...
Autores principales: | Yu, Tingting, Fu, Hao, Yang, Aoyu, Liang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243941/ https://www.ncbi.nlm.nih.gov/pubmed/37287601 http://dx.doi.org/10.1155/2023/6679871 |
Ejemplares similares
-
The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III
por: Wang, Jing, et al.
Publicado: (2022) -
A Novel Nonsense Mutation of the AGL Gene in a Romanian Patient with Glycogen Storage Disease Type IIIa
por: Zimmermann, Anca, et al.
Publicado: (2016) -
The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa
por: Qu, Qianqian, et al.
Publicado: (2020) -
Novel AGL variants in a patient with glycogen storage disease type IIIb and pulmonary hypertension caused by pulmonary veno-occlusive disease: A case report
por: Shindo, Akito, et al.
Publicado: (2023) -
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth
por: Richmond, Craig S., et al.
Publicado: (2018)